Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Proteo (PTEO)
OTHER OTC:PTEO
Proteo (PTEO) Stock Price & Analysis
2 Followers
PTEO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$285.00 - $1,250.00
Previous Close$899
Volume0.00
Average Volume (3M)N/A
Market Cap
$3.00M
Enterprise Value$2.72M
Total Cash (Recent Filing)$284.90K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,338
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.53
R-Squared0.00257
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.65K
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-10.76
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PTEO FAQ
What was Proteo’s price range in the past 12 months?
Proteo lowest stock price was $285.00 and its highest was $1250.00 in the past 12 months.
What is Proteo’s market cap?
Currently, no data Available
When is Proteo’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Proteo’s earnings last quarter?
Currently, no data Available
Is Proteo overvalued?
According to Wall Street analysts Proteo’s price is currently Overvalued.
Does Proteo pay dividends?
Proteo does not currently pay dividends.
What is Proteo’s EPS estimate?
Proteo’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Proteo have?
Currently, no data Available
What happened to Proteo’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Proteo?
Currently, no hedge funds are holding shares in PTEO
---
Proteo Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Proteo
Proteo, Inc. is a clinical stage drug development company. It intends to develop, promote, and market pharmaceuticals and other biotech products. It focuses on the development of anti-inflammatory treatments for rare diseases with significant unmet needs. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA.
---
Technical Analysis
---